Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz
Authors
Keywords
Metabolism, CYP2B6 polymorphisms, Efavirenz, Plasma concentration variations, Dosing strategies, Sex, Ethnicity
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 70, Issue 4, Pages 379-389
Publisher
Springer Nature
Online
2014-01-04
DOI
10.1007/s00228-013-1634-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cytochrome P450 pharmacogenetics in African populations
- (2013) Marco Alessandrini et al. DRUG METABOLISM REVIEWS
- Pharmacokinetic interaction between efavirenz and rifampicin in healthy volunteers
- (2013) Yenny et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients
- (2013) Marelize Swart et al. Pharmacogenetics and Genomics
- Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance
- (2013) Ulrich M. Zanger et al. Frontiers in Genetics
- Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model
- (2012) M Siccardi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Sex Differences in the Clearance of CYP3A4 Substrates: Exploring Possible Reasons for the Substrate Dependency and Lack of Consensus
- (2012) Manoranjenni Chetty et al. CURRENT DRUG METABOLISM
- Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults
- (2012) P. Byakika-Kibwika et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment
- (2012) Jing Li et al. PHARMACOGENOMICS
- Modest but Variable Effect of Rifampin on Steady-State Plasma Pharmacokinetics of Efavirenz in Healthy African-American and Caucasian Volunteers
- (2011) Awewura Kwara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of N-Glucuronidation to Efavirenz EliminationIn Vivoin the Basal and Rifampin-Induced Metabolism of Efavirenz
- (2011) Doo-Yeoun Cho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic/Pharmacogenetic Model for Optimization of Efavirenz Therapy in Caucasian HIV-Infected Patients
- (2011) Almudena Sánchez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected Zimbabweans
- (2011) Milimo Maimbo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients
- (2011) A. Habtewold et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Transporter-mediated drug–drug interactions
- (2011) Fabian Müller et al. PHARMACOGENOMICS
- In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype
- (2010) Dinko Rekić et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Long-Term Efavirenz Autoinduction and Its Effect on Plasma Exposure in HIV Patients
- (2010) E Ngaimisi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Model-Based Approach To Characterize Efavirenz Autoinduction and Concurrent Enzyme Induction with Carbamazepine
- (2009) M. Zhu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influence of the Cytochrome P450 2B6 Genotype on Population Pharmacokinetics of Efavirenz in Human Immunodeficiency Virus Patients
- (2009) S. E. Cabrera et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CYP2B6(c.516G→T) andCYP2A6(*9B and/or *17) polymorphisms are independent predictors of efavirenz plasma concentrations in HIV-infected patients
- (2009) Awewura Kwara et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Sex Differences in Pharmacokinetics and Pharmacodynamics
- (2009) Offie P. Soldin et al. CLINICAL PHARMACOKINETICS
- Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals
- (2009) M Arab-Alameddine et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Polymorphism of human cytochrome P450 enzymes and its clinical impact
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
- The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
- (2009) Filip Josephson et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Efavirenz in the therapy of HIV infection
- (2009) Natella Y Rakhmanina et al. Expert Opinion on Drug Metabolism & Toxicology
- Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz Discontinuations
- (2009) Matthijs van Luin et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-Infected Children With Tuberculosis
- (2009) Yuan Ren et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Associations betweenCYP2B6Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans
- (2009) David W. Haas et al. JOURNAL OF INFECTIOUS DISEASES
- The Role of Ethnicity in Variability in Response to Drugs: Focus on Clinical Pharmacology Studies
- (2008) SU Yasuda et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Decreased Susceptibility of the Cytochrome P450 2B6 Variant K262R to Inhibition by Several Clinically Important Drugs
- (2008) J. C. Talakad et al. DRUG METABOLISM AND DISPOSITION
- Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
- (2008) Sarah M Robertson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
- (2008) C. Wyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
- (2008) Felix W Frueh et al. PHARMACOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started